Back to Agenda
[V7-S4] Introduction to Database Study I - Introduction
Session Chair(s)
Chieko Ishiguro, PHD, MPH
Section Chief of Clinical Epidemiology, Department of Data Science, National Center for Global Health and Medicine, Japan
Rei Maeda
Consultant, Independent Consultant for Drug PV, Japan
Database studies based on secondary data analysis of automated largescale health care databases, such as claims data and electronic medical records, have been widely acknowledged and employed in postmarketing evaluations overseas. This session will outline and discuss the current issues and challenges in fully introducing and quickly realizing database studies in Japan.
Speaker(s)
Hisashi Urushihara, DrPH
Professor, Faculty of Pharmacy, Department of Pharmacy, Keio University, Japan
Introduction and Consideration
Maori Ito, MSC
Office of Medical Informatics and Science, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
The Role of Pharmacoepidemiological Study in Postmarketing Drug Safety Assessments
Shinya Kimura
Chief Executive Officer / Chairman of the Board, Japan Medical Data Center Co., Ltd., Japan
From Physician Based to Patient Based
Masaki Nakamura
Senior Manager, EBM Division, Medical Data Vision Co.,Ltd., Japan
Hospital Information System Database
Have an account?